Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection
Year: 2012
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Activated monocytes/macrophages play a role in severe forms of HIV-associated neurocognitive disorders (HAND), but little is known about the mechanisms driving milder forms that are prevalent despite combination antiretroviral therapy (cART). To examine relationships of monocyte activation markers to HAND of varying severity, we compared plasma and cerebrospinal fluid (CSF) biomarker levels with neurocognitive test scores in HIV+ subjects. METHODS: Plasma and CSF soluble CD14 (sCD14), CCL2, and interleukin (IL) 6 were measured by enzyme-linked immunosorbent assay in 67 HIV+ subjects with nadir CD4 <300, and CSF inflammatory biomarkers were measured by multiplex assay in 14 subjects on suppressive cART. RESULTS: Eighty-two percent were on cART, with 31% having undetectable plasma viral load (VL). CSF sCD14 was increased in subjects with impaired neurocognitive testing (P = 0.02), correlated inversely with global T scores in subjects with detectable but not undetectable plasma VL (P = 0.02), and yielded higher area under the receiver operating characteristic curve values for predicting impaired T scores (0.659) than plasma or CSF VL and current or nadir CD4 counts in single-marker and multivariate models. CSF sCD14, IL-6, IL-8, CCL2, CCL3, CXCL10, and interferon (IFN) gamma were increased in subjects on suppressive cART regardless of cognitive status and predicted patient class in unsupervised analyses, with IL-8, CCL2, and IFNγ explaining most of the variance. CONCLUSIONS: CSF sCD14 is associated with impaired neurocognitive testing in patients with HIV on nonsuppressive cART, suggesting potential utility as a biomarker to monitor HAND progression. CSF sCD14, IL-6, IL-8, CCL2, CCL3, CXCL10, and IFNγ remain elevated in patients on suppressive cART regardless of cognitive status, implying ongoing intrathecal inflammation even in the absence of clinical manifestations.
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: HIV-associated neurocognitive disorders, cerebrospinal fluid biomarkers, monocyte activation, soluble CD14, intrathecal inflammation, interleukin-6, interleukin-8, MCP-1, CCL3, CXCL10, interferon-gamma, neurocognitive impairment, highly active antiretroviral therapy, plasma viral load, CD4 count, neuroinflammation
Open Access status: green
Awards: Env-Receptor Interactions in HIV-1 Infection of the CNS, Texas Repository for AIDS Neuropathogenesis Research, California NeuroAIDS Tissue Network (CNTN), TEXAS REPOSITORY FOR AIDS NEUROPATHOGENESIS RESEARCH, National NeuroAIDS Tissue Consortium Statistics and Data Coordinating Center, G25173860, Mount Sinai Institutes for Clinical and Translational Sciences, CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER), National Neurological AIDS Bank, National Neurological AIDS Bank (NNAB), G4187187018, The Manhattan HIV Brain Bank, The Manahattan HIV Brain Bank, Texas Repository for AIDS Neuropathogenesis Research, The Manhattan HIV Brain Bank, California NeuroAIDS Tissue Network, Systems Biology of Immune Reconstitution in HIV / AIDS, LPS and Monocyte Activation in HIV Neuropathogenesis, NATIONAL NEUROLOGICAL AIDS BANK, NIMH HIV Brain Bank - National Coor. Office (NCO), The Mount Sinai Institute for NeuroAIDS Disparities
OpenAlex ID: W2078598685
